Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Choosing the Right Life Sciences Consultancy: A Buyer's Guide

Jul 18, 2025

Understanding the Role of Life Sciences Consultancies

In the rapidly evolving field of life sciences, consultancies play a crucial role in guiding organizations through complex challenges. Whether you are a biotech startup or a well-established pharmaceutical company, partnering with the right consultancy can significantly impact your project outcomes and strategic goals. These firms offer expertise in regulatory, scientific, and operational domains, providing essential support to navigate the intricacies of the life sciences sector.

Life sciences consultancies offer a broad range of services, including regulatory compliance, clinical trial management, market access strategies, and more. Identifying your specific needs is the first step in selecting the right partner. This decision is critical as it directly influences your project’s success and efficiency.

life sciences consulting

Factors to Consider When Choosing a Consultancy

Expertise and Experience

It’s essential to assess the expertise and experience of potential consultancies. Look for firms that have a proven track record in your specific area of need. For instance, if your focus is on regulatory affairs, a consultancy with extensive experience in navigating FDA or EMA regulations would be invaluable.

Additionally, consider the team’s qualifications. A consultancy with experts who have hands-on experience in your industry can offer practical insights and innovative solutions. This expertise translates into effective strategies that align with your organizational goals.

consulting team

Reputation and Client Testimonials

A consultancy's reputation is a strong indicator of its reliability and effectiveness. Research client testimonials and case studies to gauge past performance. Positive feedback from previous clients can provide assurance of the consultancy’s ability to deliver on its promises.

Furthermore, examine any accolades or industry recognitions the consultancy has received. These honors often reflect a commitment to excellence and can differentiate top-tier firms from the rest.

Evaluating Service Offerings and Flexibility

Comprehensive Services

The breadth of services offered by a consultancy is another vital consideration. A firm that provides a comprehensive suite of services can address multiple aspects of your project, offering seamless integration and coordination across different segments. This approach can enhance efficiency and reduce costs associated with managing multiple vendors.

service offerings

Flexibility and Customization

Every organization has unique needs. The right consultancy should offer flexible solutions that can be tailored to fit your specific requirements. During your evaluation process, discuss how potential partners can adapt their services to align with your project objectives and timelines.

Ensure that the consultancy is willing to invest time in understanding your business model and culture. This understanding fosters collaboration and ensures that the solutions provided are not only effective but also sustainable.

Cost Considerations

While cost should not be the sole factor in your decision-making process, it remains an important consideration. Seek transparent pricing structures and ensure that there are no hidden fees. A clear understanding of costs will help you manage your budget more effectively.

Request detailed proposals from shortlisted consultancies to compare their pricing against the value they offer. An investment in the right consultancy can lead to significant long-term benefits, so weigh costs against potential returns carefully.

budget planning

Final Thoughts

Choosing the right life sciences consultancy is a critical decision that can influence the trajectory of your projects and business growth. By thoroughly evaluating expertise, reputation, service offerings, flexibility, and cost, you can identify a partner that aligns with your strategic vision.

Remember, the goal is to find a consultancy that not only understands the complexities of the life sciences industry but also shares your commitment to innovation and excellence. With the right partner by your side, you can confidently navigate the challenges ahead and achieve your business objectives.